Medical News

Surgery

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Cameron MJ et al. - The authors conclude that IHC staining with the C52 monoclonal antibody is a highly sensitive and specific test that reliably distinguishes NMC from other forms of carcinoma. The NUT antibody is being prepared for commercial release and will be available in the near future.

Today in Surgical Oncology...keeping you current

A Pilot Prospective Randomized Trial of Postoperative Epoetin Alfa in Patients Undergoing Major Operation for Upper Gastrointestinal Malignancy
American Journal of Clinical Oncology, 12/07/09

Efficacy and Safety of Transarterial Chemoembolization in Recurrent Hepatocellular Carcinoma After Curative Surgical Resection
American Journal of Clinical Oncology, 12/07/09

Optimal surgery for advanced gastric cancer
Expert Review of Anticancer Therapy, 12/07/09